Anticoccidial Drugs Market Size & Dynamics

1. What is the Market Size & CAGR of Anticoccidial Drugs Market in 2021?

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.

2. COVID-19 Impact on the Anticoccidial Drugs Market

The COVID-19 pandemic has had a significant impact on the global anticoccidial drugs market. The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency.

3. Anticoccidial Drugs Dynamics

Anticoccidial drugs are agents used to treat, prevent, and control coccidial infections in animals. These drugs are crucial in maintaining animal health and preventing the spread of parasitic diseases.

4. Segments and Related Analysis

Based on the drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. The poultry animal segment led the market based on animal type. Regionally, North America dominated the global market in 2022.

5. By Region Analysis

The North American market for anticoccidial drugs held the largest market share in 2022. The APAC market is projected to grow at a CAGR of 4.3% from 2022 to 2027. Europe and Latin America also show promising growth rates in the forecast period.

6. Key Market Players and Competitive Landscape

Noteworthy companies in the global anticoccidial drugs market include Bayer Healthcare, Zoetis, Elanco, and more. The market is competitive, with players focusing on product development and partnerships to enhance market share.

7. Recent Happenings in the Anticoccidial Drugs Market

- Amlan International introduced natural alternatives to anticoccidial drugs in April 2022.

- Zoetis showcased significant weight gain in suckling calves from implants in May 2020.

- Virbac launched Multimin for cattle in September 2019.

- Ceva Sante Animale partnered with ProBioGen for poultry vaccine development using innovative technology in October 2019.